A Strategic Partner for Horizon Europe 2026-2027

The Medipol Education and Health Group, comprising Istanbul Medipol University and Ankara Medipol University, stands as a premier strategic partner for consortiums targeting the Horizon Europe (HE) 2026-2027 Work Programmes. The Group uniquely integrates vast clinical infrastructure—including the largest private hospital complex in Turkey—with robust academic capability, providing an ideal environment for pioneering research and innovation in Health Sciences and Artificial Intelligence (AI) applications. We offer deep expertise in translational research, high-quality data generation, and rapid clinical validation, aligning perfectly with the European Union’s research priorities.

Core Competencies Aligned with HE Priorities

I. Cluster 1: Health

Our institutional strengths directly address the need for data-driven healthcare solutions under HE Cluster 1. The Medipol University Hospital complex incorporates General, Cardiovascular Surgery, Oncology, and Dental specialties, generating rich, multi-modal clinical data essential for AI development.

• AI-Driven Diagnostics and Prognostics: We possess the capacity to develop and clinically validate advanced Machine Learning (ML) algorithms using large-scale patient cohorts and high-quality data from integrated systems like PACS (Picture Archiving and Communication System) and the comprehensive Hospital Information Management System.

• Personalized Medicine: The clinical integration allows for the advancement of personalized and precise treatment protocols, supported by technologies like the Pyxis Medication Management System, which ensures data integrity and adherence to international patient safety standards. Our diverse patient population provides an excellent basis for testing and generalizing AI models across various demographics.

• Resilience and Efficiency of Health Systems: Our experience with optimizing complex clinical workflows using digital solutions ("Fleet" mobile devices, Pneumatic Tube Systems) makes us highly relevant for projects focusing on optimizing critical care management, resource allocation, and overall healthcare delivery efficiency using AI/ML tools.

II. Cluster 4: Digital, Industry and Space (Health Applications)

Medipol’s technological readiness extends to projects focusing on enabling digital technologies in healthcare:

• Advanced Digital Technologies: We offer a secure, high-tech environment for researching the application of Edge Computing, medical data processing, and cybersecurity solutions within clinical settings.

• Smart Systems and Robotics: Our operational capacity, including 32 state-of-the-art operating rooms, provides a valuable platform for piloting AI-assisted surgical robotics and developing smart monitoring systems.

Unique Value Proposition for Consortiums

1. Translational Research Bridge: The seamless operational connection between our academic institutions and JCI-accredited hospitals accelerates the transformation of fundamental research into clinical innovation (T1 to T4).

2. Multidisciplinary Expertise: Our faculty profile encompasses Medicine, Engineering, Computer Science, and Biosciences, enabling high-impact interdisciplinary projects capable of leading complex HE Research and Innovation Actions (RIA) and Innovation Actions (IA).

3. Data Potential and Quality: Access to a high volume of continuously updated clinical data, coupled with institutional commitment to data governance, offers reliable resources for AI model training and validation.

We actively seek collaborative opportunities with European partners for the Horizon Europe 2026-2027 calls to jointly address critical challenges in digital health, clinical AI deployment, and sustainable healthcare systems.